Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

BridgeBio Oncology Therapeutics, Inc.

NASDAQ: BBOT · Life Sciences · 3 alerts · CIK 1869105

Share price
$1.98Close, Nov 16
Market cap
$159M
Shares outstanding
80.25MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All BridgeBio Oncology Therapeutics, Inc. filings on SEC EDGAR ↗

4:01 PM ET 8-K
Leadership Change

BridgeBio Oncology Therapeutics Leadership Change

Yong Ben, M.D., M.B.A. has resigned as the Chief Medical and Development Officer of BridgeBio Oncology Therapeutics, Inc., effective January 8, 2027. The company stated the resignation was not due to any disagreement regarding operations, policies, or practices.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.